Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Scientific Reports
|
November 16, 2024
Starvation-induced metabolic rewiring affects mTORC1 composition in vivo
Edgar Kaade, Simone Mausbach, Nina Erps, et al.
American Journal of Hematology
|
December 11, 2012
Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma
Maike Sauer, Annette Plütschow, Ron D Jachimowicz, et al.
International Journal of Cancer
|
September 30, 2023
Optical genome mapping identifies structural variants in potentially new cancer predisposition candidate genes in pediatric cancer patients
Rabea Wagener, Danielle Brandes, Marie Jung, et al.
Frontiers in Immunology
|
December 21, 2023
Mouse models of diffuse large B cell lymphoma
Areya Tabatabai, Aastha Arora, Svenja Höfmann, et al.
Cancer Discovery
|
February 22, 2014
A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDC
Felix Dietlein, Lisa Thelen, Mladen Jokic, et al.
Molecular Oncology
|
February 19, 2021
Regulation of MRE11A by UBQLN4 leads to cisplatin resistance in patients with esophageal squamous cell carcinoma
Tomohiro Murakami, Yoshiaki Shoji, Tomohiko Nishi, et al.
Molecular Cancer Therapeutics
|
April 29, 2011
Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinoma
Ron D Jachimowicz, Giulio Fracasso, Paul J Yazaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2026
Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor
Toby A Eyre, Yuqin Song, Olivier Hermine, et al.
Leukemia
|
January 26, 2026
Establishment and characterization of a CCND1-rearranged non-mantle cell lymphoma cell line and patient-derived xenograft model
Claus-Moritz Gräf, Moritz Reese, Angela Vicente-Luque, et al.
International Journal of Cancer
|
November 19, 2013
The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma
Achim Rothe, Ron D Jachimowicz, Sven Borchmann, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Scientific Reports
|
November 16, 2024
Starvation-induced metabolic rewiring affects mTORC1 composition in vivo
Edgar Kaade, Simone Mausbach, Nina Erps, et al.
American Journal of Hematology
|
December 11, 2012
Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma
Maike Sauer, Annette Plütschow, Ron D Jachimowicz, et al.
International Journal of Cancer
|
September 30, 2023
Optical genome mapping identifies structural variants in potentially new cancer predisposition candidate genes in pediatric cancer patients
Rabea Wagener, Danielle Brandes, Marie Jung, et al.
Frontiers in Immunology
|
December 21, 2023
Mouse models of diffuse large B cell lymphoma
Areya Tabatabai, Aastha Arora, Svenja Höfmann, et al.
Cancer Discovery
|
February 22, 2014
A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDC
Felix Dietlein, Lisa Thelen, Mladen Jokic, et al.
Molecular Oncology
|
February 19, 2021
Regulation of MRE11A by UBQLN4 leads to cisplatin resistance in patients with esophageal squamous cell carcinoma
Tomohiro Murakami, Yoshiaki Shoji, Tomohiko Nishi, et al.
Molecular Cancer Therapeutics
|
April 29, 2011
Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinoma
Ron D Jachimowicz, Giulio Fracasso, Paul J Yazaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2026
Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor
Toby A Eyre, Yuqin Song, Olivier Hermine, et al.
Leukemia
|
January 26, 2026
Establishment and characterization of a CCND1-rearranged non-mantle cell lymphoma cell line and patient-derived xenograft model
Claus-Moritz Gräf, Moritz Reese, Angela Vicente-Luque, et al.
International Journal of Cancer
|
November 19, 2013
The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma
Achim Rothe, Ron D Jachimowicz, Sven Borchmann, et al.
Page
of 4